CRISPR has diversified far beyond Cas9. Base editors, prime editors, CRISPR-Cas12/Cas13 and delivery mechanisms (LNPs, AAV engineering) are advancing in parallel. Relaylit tracks both foundational preprints (bioRxiv via Europe PMC) and peer-reviewed therapeutic applications.
CRISPR gene editing
Prime editing, base editing, in vivo delivery, therapeutic applications.
Example brief
Where Relaylit searches for this topic
How Relaylit tracks crispr gene editing
1. Describe it once
Paste a plain-language brief for crispr gene editing. No boolean operators, no saved-search syntax.
2. We search 4 databases
Relaylit queries PubMed, Europe PMC, arXiv and Semantic Scholar on the live APIs, deduplicates the results, and ranks each paper against your brief.
3. Read the digest
A focused, ranked email lands weekly, biweekly, or monthly — the strongest crispr gene editing work, not a raw feed.
Frequently asked questions
Related topics
Ready to track this?